February 20, 2024
ARTBIO
AlphaGen Therapeutics and ARTBIO Announce Exclusive Strategic Collaboration for the Development and Commercialization of AV001 in Greater China and on ARTBIO’s 212Pb AlphaDirect™ Technology
February 07, 2024
Septerna
Septerna Appoints Industry Veterans Bernard Coulie, M.D., Ph.D., and Shalini Sharp to its Board of Directors
February 04, 2024
Pliant Therapeutics
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
January 26, 2024
Flare Therapeutics
Flare Therapeutics Presents Fx-909 Phase 1 Dose Escalation and Expansion Clinical Trial Design at the 2024 ASCO Genitourinary Cancers Symposium
January 24, 2024
Synnovation Therapeutics
Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways